{"brief_title": "MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)", "brief_summary": "This study is to assess the safety and efficacy of an investigational drug as compared to an approved drug to reduce specific cholesterol levels.", "detailed_description": "The duration of treatment is 6 weeks.", "condition": ["Hypercholesterolemia"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0653A, ezetimibe (+) simvastatin", "Comparator: atorvastatin"], "criteria": "Inclusion Criteria: - Elevated cholesterol Exclusion Criteria: - Unstable medical conditions or significant heart problems within 3 months prior to first study visit.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "79 Years", "healthy_volunteers": "No", "mesh_term": ["Hypercholesterolemia", "Atorvastatin Calcium", "Ezetimibe", "Simvastatin"], "id": "NCT00092690"}